Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Donein25


V.TLT

RE:RE:New Press Release - Theralase(R) Announces Appointment of New Independent Director

Cetainly appears to be a great addition to our Board. However, Hepion is a...

June 6, 2023

V.TLT

RE:RE:RE:RE:RE:Fine-Tuning = 72%.

On top of that, if my math is correct...currently 91% of those with CR at 360...

June 1, 2023

V.TLT

RE:BioTuesday Update

Interesting that his CR comparison to Keytruda is at 360 days (36%) and not...

May 31, 2023

V.TLT

RE:RE:RE:Becoming a commercial-stage pharmaceutical company

That's a good idea Alamir. Why don't you slide on over to CEO.CA and...

May 25, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:How long to BTD and then AA

So if I understand you correctly; if we get an update at the end of May, it...

April 29, 2023

V.TLT

RE:RE:New Data Format

CS. The KM curve shows us at 28% for 450 day CR. You are correct that it...

April 27, 2023

V.TLT

RE:GSK buys Bellus for 2B$ to challenge MERCK’s market

What is encouraging about this acquisition is that GSK wasn't waiting...

April 18, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Looked at Q3 filing on Sedar again

Bud. If you don't care about the stock then do yourself a favor and leave...

April 14, 2023

V.TLT

RE:RE:RE:RE:New FDA Proposed Guidance on AA

A few folks (SF and Gojo) beleive it will not affect the current trial and I...

March 29, 2023

V.TLT

New FDA Proposed Guidance on AA

FDA floats 'one-trial' model for cancer drug approvals (fiercebiotech...

March 28, 2023

V.TLT

RE:RE:KRISTINA

I believe the Board elects the CEO, not the shareholders. In which case they...

March 26, 2023

V.TLT

RE:AA Application process and best practice

The way our trial is designed we actually fit well into the vision and policy...

March 10, 2023

V.TLT

RE:I find it strange

You pose an interesting question; are we in a madatory quiet period? The OSC...

March 6, 2023

V.TLT

RE:RE:News?

Actually if you look at the pattern of news releases, as you say, you will...

March 2, 2023

V.TLT

RE:RE:RE:No update for you!!

In recent quarters, Quarterly reports from TLT have been released after hours...

February 28, 2023

V.TLT

RE:RE:RE:RE:RE:Shifting narrative

I sure hope it's sooner. Been here 9 years. But for all us longs, the...

February 24, 2023

V.TLT

RE:RE:RE:Shifting narrative

Might I add that analysts have no idea what conversations are going on anyway...

February 24, 2023

V.TLT

RE:RE:RE:RE:RE:"impressive, paradigm shifting, photodynamic therapy"

Lets keep in mind AA criteria have changed recently. Now most all applicants...

February 23, 2023

V.TLT

RE:RE:RE:RE:My call for this week--

Yeah Ivan. That's him. Thanks

February 13, 2023

V.TLT

RE:RE:My call for this week--

And remember those Saturday morning radio appearances. What was the name of...

February 13, 2023

Prev 1 2 3 4 5 6 Next

Featured Company